Loading...
XASX
XRF
Market cap185mUSD
Jul 11, Last price  
2.01AUD
1D
4.15%
1Q
18.24%
Jan 2017
1,016.67%
IPO
776.90%
Name

XRF Scientific Ltd

Chart & Performance

D1W1MN
P/E
31.79
P/S
4.72
EPS
0.06
Div Yield, %
1.94%
Shrs. gr., 5y
0.58%
Rev. gr., 5y
15.57%
Revenues
60m
+8.45%
12,587,74014,706,20416,905,90912,675,25920,489,23025,886,29423,200,87021,850,06220,670,83921,132,84621,540,48924,250,36229,028,64229,081,43131,292,62740,006,80955,174,58759,835,740
Net income
9m
+15.61%
108,385920,6071,950,592302,8792,634,9833,579,3933,812,7722,441,2582,639,4631,537,264793,8511,024,0072,137,5903,121,3805,130,4556,083,7367,685,8278,885,264
CFO
8m
-3.88%
50,881354,1993,023,077773,7572,594,2563,662,2564,130,7652,612,4954,123,719425,064156,181807,7833,876,3064,201,6934,511,3873,153,8978,416,5188,089,922
Dividend
Sep 12, 20240.039 AUD/sh
Earnings
Aug 18, 2025

Profile

XRF Scientific Limited manufactures and markets precious metal products, specialized chemicals, and instruments for the scientific, analytical, construction material, and mining industries in Australia, Canada, and Europe. It operates through Capital Equipment, Precious Metals, and Consumables segments. The Capital Equipment segment designs, manufactures, and services automated fusion equipment, and high temperature test and production furnaces, as well as general laboratory equipment. The Precious Metals segment manufactures products for the laboratory and platinum alloy markets. The Consumables segment manufactures chemicals and other supplies for analytical laboratories. The company was founded in 1972 and is based in Osborne Park, Australia.
URL
https://www.xrfscientific.com
IPO date
Oct 31, 2006
Employees
Domiciled in
AU
Incorporated in
AU

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑06
Income
Revenues
59,836
8.45%
55,175
37.91%
Cost of revenue
45,457
42,509
Unusual Expense (Income)
NOPBT
14,379
12,666
NOPBT Margin
24.03%
22.96%
Operating Taxes
3,967
3,608
Tax Rate
27.59%
28.49%
NOPAT
10,412
9,058
Net income
8,885
15.61%
7,686
26.33%
Dividends
(3,601)
(2,679)
Dividend yield
1.94%
1.67%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
2,234
1,385
Long-term debt
2,907
4,568
Deferred revenue
1,639
Other long-term liabilities
132
118
Net debt
(6,907)
(15,352)
Cash flow
Cash from operating activities
8,090
8,417
CAPEX
(1,612)
(782)
Cash from investing activities
(1,643)
(782)
Cash from financing activities
(4,800)
(3,882)
FCF
6,210
5,376
Balance
Cash
12,048
10,401
Long term investments
10,903
Excess cash
9,057
18,546
Stockholders' equity
55,540
49,578
Invested Capital
49,996
33,906
ROIC
24.82%
27.33%
ROCE
23.96%
23.56%
EV
Common stock shares outstanding
137,782
136,688
Price
1.35
15.38%
1.17
105.26%
Market cap
186,006
16.31%
159,925
107.11%
EV
179,754
144,896
EBITDA
15,951
13,871
EV/EBITDA
11.27
10.45
Interest
288
222
Interest/NOPBT
2.00%
1.75%